| Schedule of Condensed Balance Sheets |
Condensed Balance Sheets
| | |
As of | |
| | |
December 31,
2025 | | |
June 30,
2025 | |
| Assets | |
| | |
| |
| Cash and cash equivalents | |
$ | 59,675 | | |
$ | - | |
| Advance to suppliers | |
| - | | |
| 7,362,203 | |
| Receivables from subsidiaries | |
| 12,350,214 | | |
| - | |
| Prepaid expenses and other receivables, net | |
| 135,727 | | |
| 612,500 | |
| Total current assets | |
| 12,545,616 | | |
| 7,974,703 | |
| Deficits in subsidiaries and VIEs | |
| (8,836,057 | ) | |
| (8,078,359 | ) |
| Total non-current asset | |
| (8,836,057 | ) | |
| (8,078,359 | ) |
| Total assets | |
| 3,709,655 | | |
| (103,656 | ) |
| | |
| | | |
| | |
| Liability | |
| | | |
| | |
| Payable to a subsidiary | |
| - | | |
| 200 | |
| Other payables | |
| 6,485,850 | | |
| - | |
| Total current liability | |
| 6,485,850 | | |
| 200 | |
| Total liability | |
| 6,485,850 | | |
| 200 | |
| | |
| | | |
| | |
| Total Shareholders’ deficit | |
$ | (2,776,291 | ) | |
$ | (103,856 | ) |
| Total liabilities and shareholders’ deficit | |
$ | 3,709,655 | | |
$ | (103,656 | ) |
|
| Schedule of Condensed Statements of Operations and Comprehensive Loss |
Condensed Statements of Operations and Comprehensive Loss
| | |
For the six-months ended | |
| | |
December 31, | |
| | |
2025 | | |
2024 | |
| Revenues | |
$ | - | | |
$ | - | |
| Income/(loss) for equity method investment in subsidiaries and VIEs | |
| - | | |
| - | |
| Selling expenses | |
| (7,606,018 | ) | |
| - | |
| General & Administrative Expenses | |
| (1,258,732 | ) | |
| - | |
| Other income, net | |
| 13 | | |
| - | |
| Share of loss of subsidiaries, consolidated VIE and VIE’s subsidiaries | |
| (634,611 | ) | |
| (484,013 | ) |
| Net loss | |
$ | (9,499,348 | ) | |
$ | (484,013 | ) |
| Other comprehensive (loss)/ income | |
$ | (123,087 | ) | |
$ | 39,797 | |
| Total Comprehensive loss | |
$ | (9,622,435 | ) | |
$ | (444,216 | ) |
|